tiprankstipranks
Advertisement
Advertisement

JP:4882 Stock Latest News

Perseus Proteomics Overhauls Board, Taps New Director to Lead Business Development
Company AnnouncementsPerseus Proteomics Overhauls Board, Taps New Director to Lead Business Development
22d ago
4882
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in FY2026
PremiumCompany Announcements
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in FY2026
28d ago
4882
Perseus Proteomics Narrows Losses but Withholds FY2027 Forecast Amid Funding Dependence
PremiumCompany Announcements
Perseus Proteomics Narrows Losses but Withholds FY2027 Forecast Amid Funding Dependence
28d ago
4882
Perseus Proteomics Wins AMED Grant to Advance PPMX-T003 for Rare Leukemia
PremiumCompany Announcements
Perseus Proteomics Wins AMED Grant to Advance PPMX-T003 for Rare Leukemia
2M ago
4882
Perseus Proteomics Sets FY2026 Forecast, Stays in Red as Licensing Push Continues
PremiumCompany Announcements
Perseus Proteomics Sets FY2026 Forecast, Stays in Red as Licensing Push Continues
2M ago
4882
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q3
PremiumCompany AnnouncementsPerseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q3
4M ago
4882
Perseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn
Premium
Company Announcements
Perseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn
4M ago
4882
Perseus Proteomics Partners with Eurus Therapeutics for Antibody Research
Premium
Company Announcements
Perseus Proteomics Partners with Eurus Therapeutics for Antibody Research
6M ago
4882
Perseus Proteomics Extends Clinical Trial for ANKL Treatment
PremiumCompany Announcements
Perseus Proteomics Extends Clinical Trial for ANKL Treatment
7M ago
4882
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
PremiumCompany Announcements
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
7M ago
4882
Perseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
PremiumCompany Announcements
Perseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
7M ago
4882
Perseus Proteomics Reports Q1 FY2026 Progress and Financial Growth
PremiumCompany Announcements
Perseus Proteomics Reports Q1 FY2026 Progress and Financial Growth
10M ago
4882
Perseus Proteomics Reports Q1 Financial Results with Continued Losses
PremiumCompany AnnouncementsPerseus Proteomics Reports Q1 Financial Results with Continued Losses
10M ago
4882
Perseus Proteomics Announces Capital Restructuring to Strengthen Financial Base
Premium
Company Announcements
Perseus Proteomics Announces Capital Restructuring to Strengthen Financial Base
1y ago
4882
Perseus Proteomics Inc. Announces Change in Accounting Auditor
Premium
Company Announcements
Perseus Proteomics Inc. Announces Change in Accounting Auditor
1y ago
4882
Perseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
PremiumCompany Announcements
Perseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
1y ago
4882
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
PremiumCompany Announcements
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
1y ago
4882
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
PremiumCompany Announcements
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
1y ago
4882
Perseus Proteomics Updates PPMX-T003 Project Details
PremiumCompany Announcements
Perseus Proteomics Updates PPMX-T003 Project Details
1y ago
4882
Perseus Proteomics’ PPMX-T003 Gains Support for Orphan Drug Development
PremiumCompany AnnouncementsPerseus Proteomics’ PPMX-T003 Gains Support for Orphan Drug Development
1y ago
4882
Perseus Proteomics Reports Financial Adjustments and Losses
Premium
Company Announcements
Perseus Proteomics Reports Financial Adjustments and Losses
1y ago
4882
Perseus Proteomics Reports Increased Sales but Continued Losses
Premium
Company Announcements
Perseus Proteomics Reports Increased Sales but Continued Losses
1y ago
4882

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >